| 2022-03-25 | -48.5% | legal | SEC EDGAR | NMTC 8-K: 8.01 (SEC Filing) |
| 2025-04-04 | -43.6% | news | Seeking Alpha | NeuroOne Medical Technologies prices $8 million public offering of common stock |
| 2022-08-03 | +35.2% | legal | SEC EDGAR | NMTC 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2025-04-03 | -34.3% | news | Seeking Alpha | NeuroOne announces public offering of shares |
| 2022-06-02 | -25.6% | legal | SEC EDGAR | NMTC 8-K: 5.07, 8.01 (SEC Filing) |
| 2024-12-10 | +25.1% | news | Seeking Alpha | NeuroOne Medical Technologies: A Small-Cap Electrode Technology Play With Multiple Catalysts Ahead |
| 2024-12-10 | +25.1% | news | Seeking Alpha | NeuroOne Medical Technologies: A Small-Cap Electrode Technology Play With Multiple Catalysts Ahead - Seeking Alpha |
| 2026-03-02 | +21.7% | news | Investing.com | Neuroone Medical stock initiated at Buy by Jones Trading - Investing.com |
| 2024-02-13 | -21.3% | legal | SEC EDGAR | NMTC 8-K: 2.02 and (SEC Filing) |
| 2026-03-03 | +18.6% | legal | MT Newswires | Neuroone Medical Technologies Insider Bought Shares Worth $670,400, According to a Recent SEC Filing |
| 2026-03-03 | +18.6% | executive | NewMediaWire | NeuroOne(R) Appoints David Wambeke as Chief Business Officer; Concurrently Completes Insider Purchase of 1 Million Shares |
| 2026-03-03 | +18.6% | M&A | TradingView | NeuroOne Medical Technologies Officer Acquires 1 Million Shares - TradingView |
| 2022-12-22 | -17.7% | legal | SEC EDGAR | NMTC 8-K: 2.02 and (SEC Filing) |
| 2022-10-25 | -17.4% | legal | SEC EDGAR | NMTC 8-K: 8.01 and (SEC Filing) |
| 2026-02-17 | -17.0% | earnings | Seeking Alpha | NeuroOne Medical Technologies GAAP EPS of -$0.03 beats by $0.01, revenue of $2.9M beats by $0.24M |
| 2026-02-17 | -17.0% | earnings | Seeking Alpha | NeuroOne targets at least $10.5M revenue in 2026 while advancing brain and pain therapy platforms |
| 2026-02-17 | -17.0% | earnings | Seeking Alpha | NeuroOne Medical Technologies Corporation (NMTC) Q1 2026 Earnings Call Transcript |
| 2026-02-17 | -17.0% | legal | SEC EDGAR | NMTC 8-K: 2.02 and (SEC Filing) |
| 2026-02-17 | -17.0% | earnings | TradingView | NeuroOne Reports Fiscal Q1 2026 Financial Results - TradingView |
| 2022-02-14 | -16.5% | legal | SEC EDGAR | NMTC 8-K: 2.02 and (SEC Filing) |
| 2023-02-14 | -16.3% | legal | SEC EDGAR | NMTC 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-12-11 | -16.0% | legal | SEC EDGAR | NMTC 8-K: 8.01 and (SEC Filing) |
| 2026-04-07 | -15.8% | news | simplywall.st | Bullish NeuroOne Medical Technologies Insiders Rewarded As Their Investment Rises To US$829.9k - simplywall.st |
| 2026-04-07 | -15.8% | news | Stock Titan | NEUROONE (NASDAQ: NMTC) director granted options and 41,929 RSUs - Stock Titan |
| 2026-04-07 | -15.8% | news | Stock Titan | Equity awards granted to NeuroOne (NMTC) director Paul Buckman - Stock Titan |
| 2026-04-07 | -15.8% | news | Stock Titan | NeuroOne (NMTC) director receives new RSU and stock option grants - Stock Titan |
| 2026-04-07 | -15.8% | news | Stock Titan | NMTC (NMTC) director gains new stock options and 41,929 RSUs - Stock Titan |
| 2023-11-07 | +14.7% | legal | SEC EDGAR | NMTC 8-K: 8.01 and (SEC Filing) |
| 2026-04-08 | -14.2% | news | Cổng thông tin điện tử Tỉnh Sơn La | Is NeuroOne (NMTC) Stock Cheap at Current Price | Price at $0.80, Down 4.00% - Private Capital - Cổng thông tin điện tử Tỉnh Sơn La |
| 2025-10-06 | +14.0% | legal | SEC EDGAR | NMTC 8-K: 2.02, 8.01 (SEC Filing) |
| 2025-07-23 | -13.4% | news | Seeking Alpha | NeuroOne receives allowance for key patent from U.S. Patent & Trademark Office |
| 2021-08-13 | +11.6% | legal | SEC EDGAR | NMTC 8-K: 2.02 and (SEC Filing) |
| 2023-11-14 | +11.2% | legal | SEC EDGAR | NMTC 8-K: 5.02, 7.01, 8.01 (SEC Filing) |
| 2024-08-07 | -11.2% | legal | SEC EDGAR | NMTC 8-K: 1.01, 2.03, 3.02 (SEC Filing) |
| 2025-12-19 | +11.1% | news | Trefis | With NeuroOne Medical Technologies Stock Surging, Have You Considered The Downside? - Trefis |
| 2025-12-11 | +10.3% | news | simplywall.st | NeuroOne Medical Technologies (NASDAQ:NMTC) Is In A Good Position To Deliver On Growth Plans - simplywall.st |
| 2025-02-04 | -10.3% | news | Seeking Alpha | NeuroOne Medical Technologies regains Nasdaq compliance |
| 2025-02-04 | -10.3% | legal | SEC EDGAR | NMTC 8-K: 8.01 and (SEC Filing) |
| 2024-05-14 | -9.5% | legal | SEC EDGAR | NMTC 8-K: 2.02 and (SEC Filing) |
| 2022-11-12 | -9.3% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for NeuroOne Medical Technologies Corporation (NMTC) - Zacks Investment Research |
| 2023-11-16 | -8.9% | legal | SEC EDGAR | NMTC 8-K: 8.01 and (SEC Filing) |
| 2021-05-25 | +8.1% | legal | SEC EDGAR | NMTC 8-K: 8.01 and (SEC Filing) |
| 2021-09-07 | +7.5% | legal | SEC EDGAR | NMTC 8-K: 8.01 and (SEC Filing) |
| 2026-03-09 | -6.6% | news | NewMediaWire | NeuroOne(R) Issues Shareholder Letter and Provides Corporate Update |
| 2022-08-11 | -6.6% | legal | SEC EDGAR | NMTC 8-K: 2.02 and (SEC Filing) |
| 2026-04-22 | -6.6% | earnings | Cổng thông tin điện tử tỉnh Tây Ninh | NMTC (NeuroOne Medical Technologies Corporation) reports sharp year over year revenue growth and narrower than expected losses to lift shares. - Dividend Report - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-04-22 | -6.6% | news | Stock Titan | Pratts disclose 7.4% stake in NeuroOne Medical (NMTC) after reverse split - Stock Titan |
| 2022-05-16 | +5.9% | legal | SEC EDGAR | NMTC 8-K: 8.01 and (SEC Filing) |
| 2024-03-26 | -5.8% | legal | SEC EDGAR | NMTC 8-K: 8.01 and (SEC Filing) |
| 2024-03-26 | -5.8% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2026-01-06 | +5.7% | news | Yahoo Finance | Best Momentum Stocks to Buy for January 6th - Yahoo Finance |
| 2025-04-07 | -5.6% | legal | SEC EDGAR | NMTC 8-K: 1.01 and (SEC Filing) |
| 2025-04-07 | -5.6% | executive | Investing.com | NeuroOne Medical's CFO Ronald McClurg buys $100,000 in stock - Investing.com |
| 2025-05-13 | +5.1% | earnings | Seeking Alpha | NeuroOne Medical Technologies Corporation 2025 Q1 - Results - Earnings Call Presentation |
| 2025-05-13 | +5.1% | earnings | Seeking Alpha | NeuroOne expects FY25 revenue to reach $8M–$10M as OneRF platform advances and new FDA submission broadens pipeline |
| 2025-05-13 | +5.1% | earnings | Seeking Alpha | NeuroOne Medical Technologies Corporation (NMTC) Q2 2025 Earnings Call Transcript |
| 2025-05-13 | +5.1% | earnings | Seeking Alpha | NeuroOne Medical Technologies GAAP EPS of -$0.07 |
| 2025-05-13 | +5.1% | legal | SEC EDGAR | NMTC 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-01-10 | +5.1% | earnings | Seeking Alpha | NeuroOne Medical Technologies announces higher Q1 prelim revenue |
| 2025-01-10 | +5.1% | legal | SEC EDGAR | NMTC 8-K: 2.02, 7.01 (SEC Filing) |
| 2023-01-13 | -4.9% | legal | SEC EDGAR | NMTC 8-K: 8.01 (SEC Filing) |
| 2025-08-14 | -4.4% | news | Seeking Alpha | NeuroOne raises product gross margin outlook to 53% as management highlights new pain management initiatives |
| 2025-08-14 | -4.4% | earnings | Seeking Alpha | NeuroOne Medical Technologies Corporation (NMTC) Q3 2025 Earnings Call Transcript |
| 2025-08-14 | -4.4% | earnings | Seeking Alpha | NeuroOne Medical Technologies GAAP EPS of -$0.03, revenue of $1.7M |
| 2025-08-14 | -4.4% | legal | SEC EDGAR | NMTC 8-K: 2.02 and (SEC Filing) |
| 2025-11-06 | -4.2% | news | Yahoo Finance | We're Hopeful That NeuroOne Medical Technologies (NASDAQ:NMTC) Will Use Its Cash Wisely - Yahoo Finance |
| 2025-10-07 | +4.2% | news | Seeking Alpha | NeuroOne Medical Technologies Corporation (NMTC) Virtual Investor Webinar Call Transcript |
| 2026-04-04 | +3.9% | legal | Stock Titan | NMTC SEC Filings - Neuroone Med Technologies Corp 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2026-04-03 | +3.9% | legal | SEC EDGAR | NMTC 8-K: 5.02, 5.07 (SEC Filing) |
| 2026-04-03 | +3.9% | news | Investing.com | NeuroOne Medical Technologies shareholders approve reverse stock split and equity plan changes - Investing.com |
| 2026-04-03 | +3.9% | news | Stock Titan | NeuroOne (NASDAQ: NMTC) wins wide reverse split, plan amendment votes - Stock Titan |
| 2026-03-17 | +3.9% | news | NewMediaWire | NeuroOne(R) Announces Publication of Clinical Experience With Its OneRF(R) sEEG-Guided Radiofrequency Ablation Technology |
| 2024-09-13 | -3.9% | legal | SEC EDGAR | NMTC 8-K: 5.02 and (SEC Filing) |
| 2025-02-12 | +3.9% | earnings | Seeking Alpha | NeuroOne projects FY 2025 revenue growth of up to 190% with Zimmer Biomet partnership |
| 2025-02-12 | +3.9% | earnings | Seeking Alpha | NeuroOne Medical Technologies Corporation (NMTC) Q1 2025 Earnings Call Transcript |
| 2025-02-12 | +3.9% | earnings | Seeking Alpha | NeuroOne Medical Technologies GAAP EPS of $0.06 |
| 2025-02-12 | +3.9% | legal | SEC EDGAR | NMTC 8-K: 2.02 and (SEC Filing) |
| 2025-02-12 | +3.9% | earnings | Yahoo Finance | NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call Highlights: Record Revenue and ... - Yahoo Finance |
| 2026-03-16 | -3.8% | news | Investing.com | Neuroone medical business development director sells $733 in NMTC stock - Investing.com |
| 2025-12-22 | -3.5% | legal | SEC EDGAR | NMTC 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-04-14 | -3.5% | news | NewMediaWire | NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance |
| 2026-04-14 | -3.5% | news | The Globe and Mail | NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance - The Globe and Mail |
| 2024-08-14 | -3.4% | earnings | Seeking Alpha | NeuroOne Medical Technologies Corporation (NMTC) Q3 2024 Earnings Call Transcript |
| 2024-08-14 | -3.4% | earnings | Seeking Alpha | NeuroOne Medical Technologies GAAP EPS of -$0.10, |
| 2024-08-14 | -3.4% | legal | SEC EDGAR | NMTC 8-K: 2.02 and (SEC Filing) |
| 2026-04-15 | +3.3% | news | NewMediaWire | NeuroOne(R) Advances Brain Drug Delivery Platform Through Collaboration With University of Minnesota |
| 2026-04-18 | +3.1% | news | Cổng thông tin điện tử Tỉnh Sơn La | NeuroOne (NMTC) Stock Breaking News (Smart Money Active) 2026-04-18 - Social Buzz Stocks - Cổng thông tin điện tử Tỉnh Sơn La |
| 2024-10-31 | -3.0% | legal | SEC EDGAR | NMTC 8-K: 1.01, 8.01 (SEC Filing) |
| 2026-04-02 | +2.9% | news | NewMediaWire | NeuroOne(R) Medical Technologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-03-12 | -2.9% | news | Seeking Alpha | NeuroOne Medical Technologies Corporation (NMTC) Discusses Platform Technology Advancements and Growth Plans for Neurological Device Applications Transcript |
| 2023-05-11 | -2.7% | legal | SEC EDGAR | NMTC 8-K: 2.02 and (SEC Filing) |
| 2025-12-16 | +2.4% | earnings | Yahoo Finance | Earnings To Watch: NeuroOne Medical Technologies Corp (NMTC) Reports Q4 2025 Result - Yahoo Finance |
| 2022-05-12 | -2.3% | legal | SEC EDGAR | NMTC 8-K: 2.02 and (SEC Filing) |
| 2026-02-26 | -1.9% | news | NewMediaWire | NeuroOne(R) to Host Virtual Investor Webinar on Thursday, March 12, 2026 at 11:30 a.m. Eastern Time |
| 2022-02-04 | +1.8% | legal | SEC EDGAR | NMTC 8-K: 5.02 (SEC Filing) |
| 2025-12-17 | +1.6% | earnings | Seeking Alpha | NeuroOne plans 2026 drug delivery commercialization as Q4 product revenue jumps 907% |
| 2025-12-17 | +1.6% | earnings | Seeking Alpha | NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript |
| 2025-12-17 | +1.6% | legal | SEC EDGAR | NMTC 8-K: 2.02 and (SEC Filing) |
| 2024-08-30 | -1.6% | news | Seeking Alpha | NeuroOne Medical files to sell 5.5M shares of common stock for holders |
| 2026-04-01 | +1.5% | news | Investing.com | Neuroone medical director Christianson sells $11k in NMTC stock - Investing.com |
| 2026-04-01 | +1.5% | executive | Stock Titan | NeuroOne (NMTC) CEO disposes shares to cover tax withholding - Stock Titan |
| 2026-04-01 | +1.5% | news | Stock Titan | NeuroOne (NMTC) executive trims stake with 15,363-share sale and tax withholding - Stock Titan |
| 2026-04-01 | +1.5% | news | Stock Titan | NMTC (NMTC) CTO uses 906 shares of common stock to cover tax liability - Stock Titan |
| 2022-02-02 | +1.4% | news | ChartMill | NMTC Stock Price, Quote & Chart | NEUROONE MEDICAL TECHNOLOGIE (NASDAQ:NMTC) - ChartMill |
| 2025-02-20 | +1.3% | legal | SEC EDGAR | NMTC 8-K: 5.02, 5.07 (SEC Filing) |
| 2023-08-14 | -1.2% | legal | SEC EDGAR | NMTC 8-K: 2.02 and (SEC Filing) |
| 2026-03-26 | -1.2% | news | NewMediaWire | NeuroOne(R) Successfully Completes Limited Market Release of OneRF(R) Trigeminal Nerve Ablation System |
| 2026-02-25 | -1.1% | legal | SEC EDGAR | NMTC 8-K: 8.01 (SEC Filing) |
| 2026-03-11 | +1.1% | news | NewMediaWire | NeuroOne(R) to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference March 17, 2026 at 1:20 p.m. Eastern Time |
| 2024-12-17 | +1.1% | earnings | Seeking Alpha | NeuroOne Medical Technologies Corporation (NMTC) Q4 2024 Earnings Call Transcript |
| 2024-12-17 | +1.1% | earnings | Seeking Alpha | NeuroOne Medical Technologies GAAP EPS of -$0.46, revenue of $3.45M |
| 2024-12-17 | +1.1% | earnings | Seeking Alpha | NeuroOne reports 77% increase in product revenue in 2024 |
| 2024-12-17 | +1.1% | legal | SEC EDGAR | NMTC 8-K: 2.02, 8.01 (SEC Filing) |
| 2025-08-18 | -0.9% | legal | SEC EDGAR | NMTC 8-K: 8.01 (SEC Filing) |
| 2021-10-04 | +0.8% | legal | SEC EDGAR | NMTC 8-K: 8.01 and (SEC Filing) |
| 2024-07-18 | -0.7% | news | InvestorPlace | 3 Neurotech Stocks Bridging Mind and Machine - InvestorPlace |
| 2025-05-12 | +0.7% | executive | Seeking Alpha | NeuroOne appoints Parag Patil as chief medical advisor |
| 2021-10-14 | +0.6% | legal | SEC EDGAR | NMTC 8-K: 1.01, 2.02, 8.01 (SEC Filing) |
| 2021-05-28 | -0.5% | news | Zacks Investment Research | Should I buy NeuroOne Medical Technologies Corporation (NMTC) - Zacks Investment Research |
| 2023-07-27 | -0.3% | legal | SEC EDGAR | NMTC 8-K: 1.01, 8.01 (SEC Filing) |
| 2025-08-15 | +0.3% | legal | SEC EDGAR | NMTC 8-K: 8.01 and (SEC Filing) |
| 2023-12-14 | +0.2% | legal | SEC EDGAR | NMTC 8-K: 2.02 and (SEC Filing) |
| 2021-12-15 | +0.2% | legal | SEC EDGAR | NMTC 8-K: 2.02 and (SEC Filing) |
| 2025-11-05 | +0.2% | news | Investing.com | NeuroOne Medical Technologies receives Nasdaq extension to regain minimum bid price compliance - Investing.com |
| 2025-11-05 | +0.2% | news | Investing.com | NeuroOne receives 180-day extension to regain nasdaq compliance - Investing.com |
| 2026-04-24 | — | news | MEXC Exchange | NMTC Price Today: NeuroOne Medical Technologies Corporation Stock Price, Quote & Chart | MEXC - MEXC Exchange |